Fri, February 24, 2023
Thu, February 23, 2023
Wed, February 22, 2023

Joshua Jennings Maintained (TNDM) at Buy with Decreased Target to $52 on, Feb 23rd, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-52-on-feb-23rd-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Joshua Jennings of Cowen & Co., Maintained "Tandem Diabetes Care, Inc." (TNDM) at Buy with Decreased Target from $61 to $52 on, Feb 23rd, 2023.

Joshua has made no other calls on TNDM in the last 4 months.



There are 3 other peers that have a rating on TNDM. Out of the 3 peers that are also analyzing TNDM, 2 agree with Joshua's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Mike Polark of "Wolfe Research" Initiated at Hold on, Thursday, January 26th, 2023
  • Larry Biegelsen of "Wells Fargo" Upgraded from Sell to Hold and Held Target at $43 on, Tuesday, November 15th, 2022


This is the rating of the analyst that currently disagrees with Joshua


  • Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $52 on, Friday, November 4th, 2022

Publication Contributing Sources